Valeant Pharmaceuticals International, Inc. (T.VRX) hit a new 52-week high of $204.02 Friday. Bankrupt drug maker Dendreon has reached a stalking-horse deal with Valeant to sell rights to its prostate cancer vaccine, Provenge, and certain assets for $296 million U.S. The deal is subject to higher and better offers until Feb. 10
Celestica Inc. (T.CLS) hit a new 52-week high of $14.20 Friday. No news announcements for today
Brookfield Asset Management Inc. (T.BAM.A) hit a new 52-week high of $65.41 Friday. No news announcements for today
Empire Company Limited (T.EMP.A) hit a new 52-week high of $91.83 Friday. No news announcements for today
iShares 1-10 Year Laddered Corporate Bond Index ETF (V.CBH) hit a new 52-week high of $20.33 Friday. No news announcements for today
Gildan Activewear Inc. (T.GIL) hit a new 52-week high of $74.07 Friday. No news announcements for today
Alimentation Couche-Tard Inc. (T.ATD.B) hit a new 52-week high of $49.51 Friday. No news announcements for today
iShares 1-10 Year Laddered Government Bond Index ETF (T.CLG) hit a new 52-week high of $20.14 Friday. No news announcements for today
Descartes Systems Group Inc. (T.DSG) hit a new 52-week high of $19.23 Friday. No news announcements for today
Molson Coors Canada Inc. (T.TPX.B) hit a new 52-week high of $98.24 Friday. No news announcements for today
